Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)
Clinical trial NCT00225992 · TERMINATED
Trial details
- NCT number
- NCT00225992
- Sponsor
- Oncology Specialties, Alabama
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2007-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.